Learn about our impact and what we’re doing to preserve the environment
Sustainability is one of our core values, and is rooted in our purpose of providing access to affordable and innovative medicines. We believe that our long-term success is closely integrated with our ability to operate in a responsible, ethical, and transparent manner, while supporting the communities we live and operate in. We are committed to advancing sustainability in the way we do business, integrating it into our decisions and strategy, and focusing on long-term sustainable growth. <br><br>Our ESG commitments are centred around creating positive social impact for our patients and employees, reducing our environmental footprint, and ensuring responsible business practices to build trust with our diverse stakeholders. Strong governance mechanisms and policy frameworks help us operationalise and deliver on our commitments, and our goal of reaching 1.5 billion patients by 2030 guides us as we work every day to enhance access, affordability, and innovation through our medicines, reduce the global disease burden, and improve patient health outcomes.
By implementing initiatives such as wastewater recovery, grey water use, and more, we reduced freshwater consumption by ~70,000 KL from April to September 2023.
By conducting site-level climate risk assessments and improving supplier engagement by sustainable procurement, we identified key vulnerabilites and reduced Scope 3 emissions intensity by 31% since FY2023.
By implementing cost improvement projects and strengthening site-level waste checks, we achieved 20-22% reduction in waste across 9 high-volume products.
By replacing fossil fuels with biofuels in boilers and expanding solar, wind, and hybrid energy use, we reduced Scope 1 and 2 emissions by 33% vs FY2023. Energy-saving initiatives also helped avoid 8,073 tonnes of CO₂ and saved 7.75 million kWh in FY2025.
Reducing carbon emissions
Reducing carbon emissions
Reducing carbon emissions
Water positivity
2nd year in a row feature in The Financial Times (London) ‘Asia-Pacific Climate Leader 2024’ list
A in MSCI
Recognised in the Leadership Category of the Indian Corporate Governance Scorecard Assessment by liAS
CII Climate Action Program (CAP) 2.0 Resilient Award
Winner, CSR Programme of the Year, Financial Express - Pharma Awards 2025
Global 500 Most Sustainable Companies 2024, Time Magazine and Statista
A- in CDP Climate Change
Silver Medal in EcoVadis
Top 5 in S&P Global ESG Rating
Winner, Top Treasury Team, Adam Smith Awards Asia 2024
Winner, Pharmaceuticals, Supply Chain and Logistics Excellence (Scale) Awards, CII Institute of Logistics
Winner, Masters of Risk - Healthcare and Pharma category awards, India Risk Management Awards
Winner, Best Trademark Portfolio, CII Industrial IP Awards 2024
Winner, R&D Excellence, CPHI & PMEC India Award 2024
ESG Excellence Award 2024, Large-Cap Pharmaceuticals & Healthcare category, KPMG
Top 15, BW Businessworld India’s Most Sustainable Companies, 2024
Listed on Dow Jones + 6 other Global ESG Indices
In 2004, we took a significant step by publishing our inaugural sustainability report. This document not only showcased our environmental impact up to that point but also outlined our ambitious goals for the future, demonstrating our commitment to sustainability and responsible practices.
Covering product responsibility, transparency, operational excellence, human dignity, equal opportunity, and community development
Environmental commitment statement (ECS) with six Environment, Social Impact and Governance (ESG) goals for 2020
We introduced the approach to integrate sustainability into our operations encompassing people, safety, quality, availability, environment, engineering excellence, productivity, continuous improvement, and community
Committed to delivering good health consistently and going beyond compliance for a <span class="text-natural-green">sustainable future</span>
We achieved three goals completely and three goals partially. Conducted materiality assessment and integrated ESG goals with purpose and business strategy.
Made sustainability core to our purpose and strategy, strengthened our sustainability commitment for the next decade
2004
2007
2010
2013
2016
2020
2022
Actions speak louder than words and nothing exemplifies this better than what we do to build better communities. At the commemoration of our founder’s passing every year, we launch Dr. Anji Reddy’s Spirit of Giving programme, where our employees across the world volunteer and contribute their time and effort to make a difference to society.
Fostering scientific temper among schoolchildren, spending time with senior citizens, bringing cheer to orphans, spreading awareness about traffic rules, working to restore a cyclone-ravaged zoo — the causes are many and diverse, but the commitment is the same
The Dr. Anji Reddy’s Spirit of Giving programme truly demonstrates the culture of giving Dr. Anji Reddy imbued in our company ethos<br>
We’re always looking for people who want to make a difference in the world<br>
